Summary of MANHATTAN PHARMACEUTICALS INC

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

MHAN.OB > SEC Filings for MHAN.OB > Form 8-K on 22-Jun-2009

All Recent SEC Filings

Show all filings for MANHATTAN PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MANHATTAN PHARMACEUTICALS INC

22-Jun-2009

Change in Directors or Principal Officers, Financial Statements and

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective June 16, 2009, Douglas Abel resigned from his positions as Chief Executive Officer and President and as an employee of Manhattan Pharmaceuticals, Inc. (the "Company") and was appointed as Chairman of the Company's Board of Directors. In addition to his role as Chairman of the Board, Mr. Abel will provide consulting services to the Company.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit 99.1 - Press release, dated June 16, 2009.

Add MHAN.OB to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for MHAN.OB - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.